You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
維康藥業(300878.SZ):公司藥品生產許可證變更 涉及增加受託生產事項
格隆匯 12-02 16:03

格隆匯12月2日丨維康藥業(300878.SZ)公佈,公司於近日取得浙江省藥品監督管理局換髮的《藥品生產許可證》,同意《藥品生產許可證》變更申請。本次變更主要涉及增加受託生產事項。

新增受託事項:“委託企業:甘正(海南)生物藥業有限公司;生產品種:二十碳五烯酸乙酯軟膠囊;受託生產地址:浙江省麗水經濟開發區遂松路2號;生產車間和生產線:製造二部二車間、製造二部三車間化學藥軟膠囊劑生產線。(僅限註冊申報使用)。”

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account